Literature DB >> 17582396

Making relative survival analysis relatively easy.

Maja Pohar1, Janez Stare.   

Abstract

In survival analysis we are interested in time from the beginning of an observation until certain event (death, relapse, etc.). We assume that the final event is well defined, so that we are never in doubt whether the final event has occurred or not. In practice this is not always true. If we are interested in cause-specific deaths, then it may sometimes be difficult or even impossible to establish the cause of death, or there may be different causes of death, making it impossible to assign death to just one cause. Suicides of terminal cancer patients are a typical example. In such cases, standard survival techniques cannot be used for estimation of mortality due to a certain cause. The cure to the problem are relative survival techniques which compare the survival experience in a study cohort to the one expected should they follow the background population mortality rates. This enables the estimation of the proportion of deaths due to a certain cause. In this paper, we briefly review some of the techniques to model relative survival, and outline a new fitting method for the additive model, which solves the problem of dependency of the parameter estimation on the assumption about the baseline excess hazard. We then direct the reader's attention to our R package relsurv that provides functions for easy and flexible fitting of all the commonly used relative survival regression models. The basic features of the package have been described in detail elsewhere, but here we additionally explain the usage of the new fitting method and the interface for using population mortality data freely available on the Internet. The combination of the package and the data sets provides a powerful informational tool in the hands of a skilled statistician/informatician.

Entities:  

Mesh:

Year:  2007        PMID: 17582396     DOI: 10.1016/j.compbiomed.2007.04.010

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  21 in total

1.  Risk of Death among HIV Co-Infected Multidrug Resistant Tuberculosis Patients, Compared To Mortality in the General Population of South Africa.

Authors:  Samuel Om Manda; Lieketseng J Masenyetse; Joey L Lancaster; Martie L van der Walt
Journal:  J AIDS Clin Res       Date:  2013-07-02

2.  Baseline mortality-adjusted survival in colon cancer patients.

Authors:  Kristjan Ukegjini; Marcel Zadnikar; Rene Warschkow; Sascha Müller; Bruno M Schmied; Lukas Marti
Journal:  Langenbecks Arch Surg       Date:  2016-04-21       Impact factor: 3.445

Review 3.  Survival analysis in hematologic malignancies: recommendations for clinicians.

Authors:  Julio Delgado; Arturo Pereira; Neus Villamor; Armando López-Guillermo; Ciril Rozman
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

4.  Blood transfusion does not adversely affect survival after elective colon cancer resection: a propensity score analysis.

Authors:  Ignazio Tarantino; Kristjan Ukegjini; Rene Warschkow; Bruno M Schmied; Thomas Steffen; Alexis Ulrich; Sascha A Müller
Journal:  Langenbecks Arch Surg       Date:  2013-07-11       Impact factor: 3.445

5.  Convergence with SEER database achieved by a breast cancer network: a longitudinal benchmark of 5-year relative survival.

Authors:  Christian O Jacke; Ute S Albert; Iris Reinhard; Matthias Kalder
Journal:  J Cancer Res Clin Oncol       Date:  2014-12-16       Impact factor: 4.553

6.  Baseline mortality-adjusted survival in resected rectal cancer patients.

Authors:  Ignazio Tarantino; Sascha A Müller; Rene Warschkow; Yakup Kulu; Bruno M Schmied; Markus W Büchler; Alexis Ulrich
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

7.  Long-Term Survival is not Impaired After the Complete Resection of Neuroendocrine Tumors of the Appendix.

Authors:  Thomas Steffen; Sabrina M Ebinger; René Warschkow; Cornelia Lüthi; Bruno M Schmied; Thomas Clerici
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

8.  Do Patients Live Longer After THA and Is the Relative Survival Diagnosis-specific?

Authors:  Peter Cnudde; Ola Rolfson; A John Timperley; Anne Garland; Johan Kärrholm; Göran Garellick; Szilard Nemes
Journal:  Clin Orthop Relat Res       Date:  2018-06       Impact factor: 4.176

9.  Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.

Authors:  Alix Augustin; Steven Le Gouill; Rémy Gressin; Aurélie Bertaut; Alain Monnereau; Anne-Sophie Woronoff; Brigitte Trétarre; Patricia Delafosse; Xavier Troussard; Anne Moreau; Olivier Hermine; Marc Maynadié
Journal:  J Cancer Res Clin Oncol       Date:  2017-10-11       Impact factor: 4.553

10.  Using relative survival measures for cross-sectional and longitudinal benchmarks of countries, states, and districts: the BenchRelSurv- and BenchRelSurvPlot-macros.

Authors:  Christian O Jacke; Iris Reinhard; Ute S Albert
Journal:  BMC Public Health       Date:  2013-01-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.